BI
TBRA

BVF Inc’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BVF Inc’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-399,433
Closed -$15.9M – 32
2016
Q3 		$15.9M Sell
399,433
-853,968
-68% -$9.53M 2.99% 13
2016
Q2 		$15.7M Hold
1,253,401
– – 3.35% 12
2016
Q1 		$10.3M Hold
1,253,401
– – 2.54% 17
2015
Q4 		$12.6M Buy
1,253,401
+78,168
+7% +$812K 2.15% 17
2015
Q3 		$11.4M Hold
1,175,233
– – 2.29% 15
2015
Q2 		$20.3M Buy
1,175,233
+966,064
+462% +$14.1M 3.58% 12
2015
Q1 		$2.3M Hold
209,169
– – 0.48% 24
2014
Q4 		$1.72M Sell
209,169
-80,508
-28% -$693K 0.33% 27
2014
Q3 		$2.95M Hold
289,677
– – 0.61% 21
2014
Q2 		$17.7M Buy
289,677
+105,334
+57% +$6.41M 2.8% 12
2014
Q1 		$20.8M Hold
184,343
– – 3.22% 11
2013
Q4 		$7.91M Hold
184,343
– – 1.38% 14
2013
Q3 		$11.1M Buy
+184,343
New +$9.66M 1.91% 12

BVF Inc's TBRA Position: Q4 2016 in Review

BVF Inc sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 399,433 shares — an estimated $15.9M sold.

BVF Inc first reported a position in TBRA in Q3 2013 and held it in 13 quarters. The position peaked at $20.8M in Q1 2014. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • BVF Inc reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • BVF Inc sold 399,433 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $15.9M.
  • BVF Inc first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 13 quarters.
  • BVF Inc's Tobira Therapeutics, Inc. Common Stock position peaked at $20.8M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BVF Inc's 13F filing for Q4 2016, filed 14 Feb 2017.